Načítá se...
Silent hypoxia in COVID-19: pathomechanism and possible management strategy
The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although...
Uloženo v:
| Vydáno v: | Mol Biol Rep |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8062941/ https://ncbi.nlm.nih.gov/pubmed/33891272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11033-021-06358-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|